SOPHiA GENETICS Chief Scientific Officer Xu Zhenyu sold 4,000 shares at $7.88 per share. The transaction represented about 0.7% of his prior holding, while his reported ownership afterward stood at 552,887 shares, giving investors the disclosed post-sale position and transaction scale.

Key Highlights

  • The transaction took place on September 14, 2026, under SEC transaction code S.
  • Xu Zhenyu owned 552,887 SOPHiA GENETICS shares after the transaction.
  • The sale represented about 0.7% of Xu Zhenyu’s prior share holding.

SOPHiA GENETICS SA (NASDAQ: SOPH) recorded a sale of 4,000 shares at $7.88 per share by Chief Scientific Officer Xu Zhenyu. The transaction sets out the reported price and size of the insider share sale.

Transaction Dated September 14

The transaction date was September 14, 2026. SEC transaction code S identifies the entry as a sale. Xu Zhenyu’s position after the transaction was reported at 552,887 shares. The named seller’s role at SOPHiA GENETICS SA is Chief Scientific Officer.

Sale Equals 0.7% of Prior Holding

The transaction represented about 0.7% of Xu Zhenyu’s prior share holding. That percentage is the disclosed comparison between the sale and his ownership before the transaction. The reported transaction size, price and post-sale holding are the stated measures. The reported comparison is specific to the Chief Scientific Officer’s ownership.